Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354627
Status:
COMPLETED
Last Update Posted:
2015-06-12
First Post:
2006-07-18
Brief Title:
The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Organization Data
Organization:
Tibotec Pharmaceuticals Ireland
Class:
INDUSTRY
Study ID:
CR002743
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tibotec Pharmaceuticals Ireland
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None